01—Abstract
Summary
Summary of the 8-K filed April 24, 2024. Cited figures are marked; the original filing is the authoritative source.
Bunge Global SA (NYSE: BG) reported first quarter 2024 results on April 24, 2024.
GAAP diluted EPS was $1.68a, down sharply from $4.15 a year earlier, and net income attributable to Bunge fell to $244 million from $632 million. On an adjusted basis, which excludes mark-to-market timing differences and certain charges, EPS was $3.04 versus $3.26 in the prior year, a modest decline. The quality of the quarter is the key takeaway: the adjusted decline was contained because Agribusiness Processing improved sharply in Europe and Asia, but this was more than offset by weaker Merchandising results, lower Refined and Specialty Oils earnings from a strong prior-year base, and higher corporate costs tied to the pending Viterra combination.
Adjusted Core Segment EBIT was $719 millionb versus $756 million, and Adjusted Total Segment EBIT was $676 million versus $695 million. Cash generation and capital returns were mixed. Cash from operations rose slightly to $994 million, but Adjusted FFO fell to $514 million from $625 million, and working capital changes absorbed $610 million.
Bunge repurchased $400 millionc of shares during the quarter, and net debt-related balance sheet items rose, with short-term debt increasing to $1,010 million. Management maintained its full-year 2024 adjusted EPS outlook of approximately $9.00, while noting limited visibility into the second half of the year. Guidance also lowered net interest expense to $280-310 million from $300-330 million.
The company flagged that Processing margins remain compressed in most regions and that Sugar & Bioenergy is expected to decline significantly on lower Brazilian ethanol prices. The filing also highlights $61 milliond of pre-tax acquisition and integration costs tied to the announced Viterra business combination, which depressed GAAP results. Investors should watch integration progress, the second-half margin outlook, and whether the company can sustain its share repurchases while funding growth projects and deleveraging considerations associated with the transaction.
02—Key points
Key Highlights
- GAAP diluted EPS of $1.68 versus $4.15 a year ago; adjusted EPS of $3.04 versus $3.26, a decline of about 7%.
- Agribusiness Processing EBIT rose to a strong result in Europe and Asia, but this was more than offset by lower Merchandising results (Merchandising EBIT adjusted $76 million versus $108 million).
- Refined and Specialty Oils Segment EBIT fell to $226 million from $233 million on a GAAP basis and adjusted to $204 million from $234 million, reflecting a shift in U.S. supply conditions after a record prior year.
- $61 million of pre-tax acquisition and integration costs related to the Viterra business combination reduced GAAP net income.
- Adjusted Funds From Operations declined to $514 million from $625 million, weighed down by $610 million of working capital outflow, even though operating cash flow was $994 million.
- Bunge repurchased $400 million of shares in the quarter, while short-term debt rose to $1,010 million from $797 million.
- Full-year 2024 adjusted EPS outlook maintained at approximately $9.00, with net interest expense guidance lowered to $280-310 million and capital expenditures guided to $1.2-1.4 billion.
03—Questions
Frequently Asked Questions
Why did GAAP EPS decline so much more than adjusted EPS?
The gap reflects mark-to-market timing differences and certain charges. In Q1 2024, mark-to-market timing differences reduced GAAP EPS by $0.94 (versus a $0.84 benefit in the prior year), and acquisition and integration costs related to Viterra reduced EPS by $0.42. Those swings are largely accounting timing effects tied to economically hedged positions rather than operating performance, so management's adjusted EPS of $3.04 is a better gauge of underlying results, though it is a non-GAAP measure.
Is Bunge's full-year 2024 earnings outlook still intact?
Yes. Bunge reaffirmed its full-year 2024 adjusted EPS outlook of approximately $9.00. Management said Agribusiness and Refined and Specialty Oils are expected to be similar to prior guidance but lower than 2023, Milling and Corporate and Other are expected to be up year over year, and Sugar & Bioenergy is expected to be significantly down. Management also said it has limited visibility into the second half of the year, so investors should weigh that uncertainty.
Why did operating cash flow rise while Adjusted FFO fell?
Reported operating cash flow of $994 million benefited from working capital changes, but Adjusted FFO excludes working capital changes and mark-to-market timing differences. Adjusted FFO of $514 million was lower than $625 million a year earlier, with working capital changes of $(610) million in the quarter versus $(201) million in the prior-year period, which the company's non-GAAP reconciliation treats as a reduction.
What is the status of the Viterra transaction in this filing?
The filing describes significant progress on integration planning for the announced combination with Viterra. Bunge recorded $61 million of pre-tax acquisition and integration costs in Q1 2024, including $4 million in interest expense for financing fees and $61 million in SG&A for other transaction-related costs. Investors should expect these costs to continue and should monitor the risk factors and forward-looking statements that cite the pending Viterra business combination.
Why did the company reduce its interest expense outlook?
Bunge lowered its 2024 net interest expense guidance to $280-310 million from $300-330 million. The filing does not give a detailed explanation, but the change suggests lower expected borrowing costs or net debt levels than previously forecast. Interest income in the quarter was $42 million and interest expense was $108 million.
04—Continue